TAGRISSO

Описание товара

About TAGRISSO

TAGRISSO is a medication containing the active ingredient osimertinib mesylate. Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations. It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor.

Key Benefits & Uses

• Used for: Osimertinib, sold under the brand name Tagrisso, is a medication used to treat non-small-cell lung carcinomas with specific mutations
• Used for: It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

osimertinib mesylate, the active ingredient in TAGRISSO, is the pharmacologically active substance of this product. Its clinical use follows the authorised labelling for osimertinib mesylate-containing medicines. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking TAGRISSO. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use TAGRISSO for extended periods without medical advice.